The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Good morning. My name is Vincent, and I'll be your conference operator today. At this time, I would like to welcome everyone to the SOPHiA GENETICS First Quarter 2026 Earnings Conference Call.

Greetings. Welcome to Fulgent Genetics First Quarter 2026 Conference Call and Webcast. [Operator Instructions] please note, this conference is being recorded. I will now turn the conference over to ...

Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave a rapid clearance to its OTOF-targeting medicine Otarmeni. In a remarkable ...

SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE)-- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its first ...

BOSTON and ROLLE, Switzerland, April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free ...

Scientists at Keele University have created the first detailed map of the genetic "switches" that control reproduction in disease-carrying insects such as Anopheles gambiae, the mosquito species most ...

Horses were being ridden, worked, and traded long before anyone thought it possible. New research pushes back the accepted ...

Children born deaf because of a rare condition can now take a drug to restore their hearing after a gene therapy was approved in the U.S., ushering in a new era for the treatment of an inherited form ...